Abstract
Atherosclerosis is one major cause of cardiovascular diseases, the leading cause of death in industrialized countries. Reverse cholesterol transport (RCT) is thought to be one primary pathway to protect against atherosclerosis. The first and rate-limiting step of RCT is ATP-binding cassette transport A1 (ABCA1) and ABCG1-mediated cholesterol efflux from the cells. Recently, caveolin-1 (CAV1), a scaffolding protein that organizes and concentrates certain caveolininteracting signaling molecules and receptors within caveolae membranes, has been shown to regulate ABCA1 and ABCG1-mediated cholesterol efflux probably via interacting with them. In the present review, we summarize the current knowledge and views on the regulatory role of CAV1 on the cholesterol homeostasis with emphasis on the association of CAV1 with ABCA1 and ABCG1. We conclude that the dominance of the positive regulation by CAV1 on the ABCA1 and ABCG1-mediated cholesterol efflux is depending on the species, cell types, as well as the levels of CAV1 expression.
Keywords: Atherosclerosis, ATP binding cassette transporter, caveolin 1, reverse cholesterol transport.
Cardiovascular & Hematological Disorders-Drug Targets
Title:Caveolin-1 and ATP Binding Cassette Transporter A1 and G1-Mediated Cholesterol Efflux
Volume: 14 Issue: 2
Author(s): Faqi Wang, Hong-mei Gu and Da-wei Zhang
Affiliation:
Keywords: Atherosclerosis, ATP binding cassette transporter, caveolin 1, reverse cholesterol transport.
Abstract: Atherosclerosis is one major cause of cardiovascular diseases, the leading cause of death in industrialized countries. Reverse cholesterol transport (RCT) is thought to be one primary pathway to protect against atherosclerosis. The first and rate-limiting step of RCT is ATP-binding cassette transport A1 (ABCA1) and ABCG1-mediated cholesterol efflux from the cells. Recently, caveolin-1 (CAV1), a scaffolding protein that organizes and concentrates certain caveolininteracting signaling molecules and receptors within caveolae membranes, has been shown to regulate ABCA1 and ABCG1-mediated cholesterol efflux probably via interacting with them. In the present review, we summarize the current knowledge and views on the regulatory role of CAV1 on the cholesterol homeostasis with emphasis on the association of CAV1 with ABCA1 and ABCG1. We conclude that the dominance of the positive regulation by CAV1 on the ABCA1 and ABCG1-mediated cholesterol efflux is depending on the species, cell types, as well as the levels of CAV1 expression.
Export Options
About this article
Cite this article as:
Wang Faqi, Gu Hong-mei and Zhang Da-wei, Caveolin-1 and ATP Binding Cassette Transporter A1 and G1-Mediated Cholesterol Efflux, Cardiovascular & Hematological Disorders-Drug Targets 2014; 14(2) . https://dx.doi.org/10.2174/1871529X14666140505122802
DOI https://dx.doi.org/10.2174/1871529X14666140505122802 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
[General Articles] Natriuretic Peptides in Alcohol Withdrawal: Central and Peripheral Mechanisms
Current Medicinal Chemistry Clinical Applications of Nanotechnology in Atherosclerotic Diseases
Current Nanoscience Cardiac Biomarkers in Acute Coronary Syndromes: A Review
Current Vascular Pharmacology Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Current Alzheimer Research Hemopoietic Cells with Features of the Mast Cell and Basophil Lineages and their Potential Role in Allergy
Current Drug Targets - Inflammation & Allergy Arrhythmia Pharmacogenomics: Methodological Considerations
Current Pharmaceutical Design Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism Inhaled Corticosteroids in COPD: Pros and Cons
Current Drug Targets COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures
Coronaviruses Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?
Inflammation & Allergy - Drug Targets (Discontinued) Recent Advances in Treatment Approaches to Gaucher Disease
Current Pharmaceutical Biotechnology ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Current Status of Lung Ventilation Imaging with Magnetic Resonance Ventilation Scanning Using Aerosolized Contrast Agents
Current Respiratory Medicine Reviews Novel Coronavirus Disease (COVID-19): A Narrative Review Based on Current Status
Anti-Infective Agents Regulatory T Cells and Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) Edema, Inflammation and Fibrosis – Comparison Between Catecholamine- and Hypoxia-Induced Pulmonary Injuries
Vascular Disease Prevention (Discontinued) The Neuropharmacology of (-)-Stepholidine and its Potential Applications
Current Neuropharmacology Effects of Exercise on Anxiety and Depression Disorders: Review of Meta- Analyses and Neurobiological Mechanisms
CNS & Neurological Disorders - Drug Targets Gene Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Integrins Modulate Cellular Fibrogenesis at Multiple Levels: Regulation of TGF-β Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets